Apogee Enterprises Reports Q1 Fiscal 2027 Net Sales Drop

By Hao Liu • Friday, June 26 10:57 • Permanent Link

Apogee Enterprises reported first-quarter fiscal 2027 net sales of $342.7 million, down 1.1% from $346.6 million a year earlier, as lower volume outweighed pricing gains.

Operating income climbed to $18.8 million from $6.9 million, while operating margin widened to 5.5% from 2.0%. Net earnings improved to $11.5 million from a loss of $2.7 million, and diluted earnings per share rose to $0.54 from a loss of $0.13.

Adjusted EBITDA fell to $32.1 million from $34.4 million, and adjusted EBITDA margin slipped to 9.4% from 9.9%. Adjusted diluted EPS edged up to $0.57 from $0.56.

Gross margin increased to 21.9% from 21.7%, while SG&A expenses as a percentage of sales dropped to 16.4% from 19.7%. Interest expense declined to $2.8 million from $3.8 million.

By segment, architectural metals sales fell 4.8% to $122.4 million, but adjusted EBITDA rose to $13.7 million from $9.4 million, lifting margin to 11.2% from 7.3%.

Architectural services sales increased 8.2% to $115.2 million, while adjusted EBITDA was flat at $6.1 million; margin slipped to 5.3% from 5.7%. Segment backlog rose to $734.5 million from $682.9 million at the end of fiscal 2026.

Architectural glass sales declined 7.6% to $67.7 million, and adjusted EBITDA dropped to $5.9 million from $13.4 million, cutting margin to 8.7% from 18.3%.

Performance surfaces sales rose 4.9% to $44.3 million, but adjusted EBITDA fell to $6.6 million from $8.0 million, with margin down to 14.8% from 18.8%. As a result of these announcements, the company's shares have moved 15.56% on the market, and are now trading at a price of $49.09. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.